In cases of inherited bleeding disorder VWD, which is classified into several types, dDAVP is theoretically useful in the treatment of type 1 VWD (patients with functionally normal von Willebrand’s factor—vWF). This evidence concerns the gene VWF and von Willebrand disease 1.